Event Description
Topic
Diffuse Gliomas: Summary of the Major Changes in the 2016 WHO Classification of Tumors of the CNS
Presented By
Armine Darbinyan, MD, cytopathology fellow, and the former Joseph Schein Endowed Fellow in Neuropathology and
Experimental/Molecular Pathology, Icahn School of Medicine at Mount Sinai
Target Audience
Attending pathologists from within Drexel University College of Medicine, its affiliated hospitals and
private practice pathologists and pathology fellows.
Educational Objectives
Physicians will acquire up-to-date knowledge about specific aspects of pathology theory and practice. Physicians will be exposed to content information in specialty areas of pathology which are not a routine aspect of their clinical practice, but are able to enhance their clinical practice.
ACCREDITATION STATEMENT
Drexel University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA Credit Designation Statement: The Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOA
This program is eligible for 1 credit in Category 2A of the American Osteopathic Association.
Faculty Disclosure Statement
Speakers at continuing medical education activities are required to disclose to the audience any relevant commercial interest (which is any entity producing, marketing, reselling or distributing health care goods or services consumed by or used on patients) Any conflicts of interest must be resolved prior to the presentation and announced to the audience.
Faculty Disclosure
Dr. Darbinyan has no commercial relationships to disclose.
The following Planning Committee members have no commercial relationships to disclose: Drs. C. Hanau, S. Hou and B. Mapow.
|